Related Experiment Video
Updated: May 17, 2026

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
Published on: February 15, 2022
Conjunctival modifications induced by medical and surgical therapies in patients with glaucoma
Leonardo Mastropasqua1, Luca Agnifili, Rodolfo Mastropasqua
1Department of Medicine and Ageing Science, Ophthalmic Clinic, University G. d'Annunzio of Chieti-Pescara, Chieti, Italy. mastropa@unich.it
Abstract:
Lowering intra-ocular pressure, either medically or surgically, is the proven strategy to control glaucoma, though profound changes to the ocular surface and conjunctiva are caused. Toxicity and allergy initiated by medical therapy induce modifications, which progressively worsen with the length of treatment and number of drugs. Conjunctival changes lead to symptoms of ocular surface disease, reduced quality of life, reduced therapeutic compliance and increased risk of surgical failure. Surgery modifies conjunctiva by inducing bleb formation in fistulizing techniques, and by activating secondary aqueous humour outflow pathways, such as trans-scleral routes, in both filtration and bleb-less approaches. The use of unpreserved medications, limitation of intra-operative conjunctival damage and development of bleb-less surgery are advisable.
Insights
Glaucoma treatment via medication or surgery significantly alters the conjunctiva and ocular surface. Strategies like unpreserved medications and bleb-less surgery can mitigate these harmful effects.
Area of Science:
- Ophthalmology
- Ocular Surface Disease
- Glaucoma Management
Background:
- Lowering intraocular pressure (IOP) is crucial for glaucoma control.
- Medical and surgical glaucoma treatments profoundly impact the conjunctiva and ocular surface.
- Long-term medical therapy can lead to toxicity and allergic reactions, worsening ocular surface disease.
Purpose of the Study:
- To analyze the effects of glaucoma treatments on the conjunctiva and ocular surface.
- To identify strategies for mitigating treatment-induced ocular surface complications.
- To improve patient quality of life and therapeutic compliance in glaucoma management.
Main Methods:
- Review of existing literature on glaucoma treatment modalities and their ocular surface effects.
- Analysis of conjunctival modifications induced by medical therapies (toxicity, allergy).
- Evaluation of surgical techniques (fistulizing, filtration, bleb-less) and their impact on conjunctival integrity and aqueous humor outflow.
Main Results:
- Medical glaucoma therapies can cause progressive conjunctival changes, leading to ocular surface disease.
- These changes negatively affect quality of life, treatment adherence, and surgical outcomes.
- Surgical interventions, including bleb formation or trans-scleral routes, also alter conjunctival tissue.
Conclusions:
- Minimizing conjunctival damage during glaucoma surgery is advisable.
- Utilizing unpreserved medications can reduce treatment-related toxicity and allergy.
- Development and adoption of bleb-less surgical techniques may offer a safer alternative for glaucoma management.
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Microbiome of the Eye
Ophthalmic Drug Delivery Systems
Accessory Structures of the Eye
